Jin Medical International Stock Performance
| ZJYL Stock | 0.68 0.09 11.69% |
The company retains a Market Volatility (i.e., Beta) of 0.34, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, JIN MEDICAL's returns are expected to increase less than the market. However, during the bear market, the loss of holding JIN MEDICAL is expected to be smaller as well. JIN MEDICAL INTERNATIONAL currently retains a risk of 8.65%. Please check out JIN MEDICAL downside variance, as well as the relationship between the daily balance of power and relative strength index , to decide if JIN MEDICAL will be following its current trending patterns.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days JIN MEDICAL INTERNATIONAL has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, JIN MEDICAL is not utilizing all of its potentials. The newest stock price mess, may contribute to short-term losses for the institutional investors. ...more
Last Split Factor 20:1 | Last Split Date 2024-02-08 |
1 | The Returns On Capital At Jin Medical International Dont Inspire Confidence | 03/18/2025 |
2 | Jin Medical International Shares Down 7.7 percent - Heres What Happened - MarketBeat | 04/07/2025 |
3 | Jin Medical Boosts Production Capacity with New Chuzhou Facility - TipRanks | 04/25/2025 |
4 | Jin Medical International Ltd. Nasdaq Minimum Bid Price Non-Compliance | 05/06/2025 |
5 | Jin Medical International Stock Price Up 5 percent - Should You Buy - MarketBeat | 05/09/2025 |
| Begin Period Cash Flow | 6.9 M |
JIN MEDICAL Relative Risk vs. Return Landscape
If you would invest 84.00 in JIN MEDICAL INTERNATIONAL on March 12, 2025 and sell it today you would lose (16.00) from holding JIN MEDICAL INTERNATIONAL or give up 19.05% of portfolio value over 90 days. JIN MEDICAL INTERNATIONAL is currently generating 0.038% in daily expected returns and assumes 8.6547% risk (volatility on return distribution) over the 90 days horizon. In different words, 77% of stocks are less volatile than JIN, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
JIN MEDICAL Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for JIN MEDICAL's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as JIN MEDICAL INTERNATIONAL, and traders can use it to determine the average amount a JIN MEDICAL's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0044
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ZJYL |
Estimated Market Risk
| 8.65 actual daily | 77 77% of assets are less volatile |
Expected Return
| 0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average JIN MEDICAL is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of JIN MEDICAL by adding JIN MEDICAL to a well-diversified portfolio.
JIN MEDICAL Fundamentals Growth
JIN Stock prices reflect investors' perceptions of the future prospects and financial health of JIN MEDICAL, and JIN MEDICAL fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on JIN Stock performance.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0578 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.19 % | ||||
| Current Valuation | 105.34 M | ||||
| Shares Outstanding | 156.55 M | ||||
| Price To Book | 4.18 X | ||||
| Price To Sales | 5.13 X | ||||
| Revenue | 23.5 M | ||||
| Gross Profit | 9.61 M | ||||
| EBITDA | 3.98 M | ||||
| Net Income | 3.42 M | ||||
| Total Debt | 11.6 M | ||||
| Book Value Per Share | 0.18 X | ||||
| Cash Flow From Operations | (1.21 M) | ||||
| Earnings Per Share | 0.02 X | ||||
| Market Capitalization | 120.49 M | ||||
| Total Asset | 45.8 M | ||||
| Retained Earnings | 20.02 M | ||||
| Working Capital | 25.66 M | ||||
About JIN MEDICAL Performance
By examining JIN MEDICAL's fundamental ratios, stakeholders can obtain critical insights into JIN MEDICAL's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that JIN MEDICAL is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 167.02 | 146.42 | |
| Return On Tangible Assets | 0.09 | 0.14 | |
| Return On Capital Employed | 0.15 | 0.26 | |
| Return On Assets | 0.09 | 0.14 | |
| Return On Equity | 0.15 | 0.24 |
Things to note about JIN MEDICAL INTERNATIONAL performance evaluation
Checking the ongoing alerts about JIN MEDICAL for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for JIN MEDICAL INTERNATIONAL help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| JIN MEDICAL had very high historical volatility over the last 90 days | |
| JIN MEDICAL has some characteristics of a very speculative penny stock | |
| JIN MEDICAL generates negative cash flow from operations | |
| About 76.0% of the company outstanding shares are owned by insiders |
- Analyzing JIN MEDICAL's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether JIN MEDICAL's stock is overvalued or undervalued compared to its peers.
- Examining JIN MEDICAL's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating JIN MEDICAL's management team can have a significant impact on its success or failure. Reviewing the track record and experience of JIN MEDICAL's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of JIN MEDICAL's stock. These opinions can provide insight into JIN MEDICAL's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in JIN MEDICAL INTERNATIONAL. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of JIN MEDICAL. If investors know JIN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about JIN MEDICAL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.676 | Earnings Share 0.02 | Revenue Per Share | Quarterly Revenue Growth 0.353 | Return On Assets |
The market value of JIN MEDICAL INTERNATIONAL is measured differently than its book value, which is the value of JIN that is recorded on the company's balance sheet. Investors also form their own opinion of JIN MEDICAL's value that differs from its market value or its book value, called intrinsic value, which is JIN MEDICAL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because JIN MEDICAL's market value can be influenced by many factors that don't directly affect JIN MEDICAL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between JIN MEDICAL's value and its price as these two are different measures arrived at by different means. Investors typically determine if JIN MEDICAL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, JIN MEDICAL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.